BackCardio Diagnostics Holdings Overview

Cardio Diagnostics Holdings EBIT

Latest ebit for CDIO: $7.7K, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$1.73M
↑ 3.93% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

$7.71K
↑ 100.11% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Cardio Diagnostics Holdings (CDIO) FAQ

The latest EBIT for CDIO is $7.7K as of September 2026. That compares with $-6.7M in the prior-year period — up 100.1% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Cardio Diagnostics Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, CDIO's EBIT moved from $-6.7M to $7.7K — a 100.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cardio Diagnostics Holdings's operating scale or balance-sheet position.

Against its sector companies, CDIO currently prints $7.7K for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Cardio Diagnostics Holdings's growth, margins, and balance sheet.

A EBIT figure of $7.7K for CDIO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting CDIO's EBIT ($7.7K), review year-over-year change from $-6.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.